×
0 0 0 0 0 0 0.0256107752052303 0.0256107752052303
Stockreport

Regeneron and Sanofi Offer Praluent® (alirocumab) at a New Reduced U.S. List Price

Regeneron Pharmaceuticals, Inc (REGN)  More Company Research Source: PR Newswire
Last regeneron pharmaceuticals, inc earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF TARRYTOWN, N.Y. and BRIDGEWATER, N.J., Feb. 11, 2019 /PRNewswire/ --This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients Beginning in early March 2019, new U.S. National Drug Code (NDC) options will be available at approximately 60% less than the original price Out-of-pocket costs for Medicare patients could be lowered to approximately $25 to $150 per month, a potential savings of up to $345,* depending on their insurance planRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that Praluent® (alirocumab) will be made available at a new reduced U.S. list price of $5,850 annually, a 60% reduction from the original price, for both the 75 mg and 150 mg doses, beginning in early March.   The new lower-priced Praluent is expected to result in lower patient out-of-pocket costs and represents another step in the companies' efforts to help improve patient affordability and access. This follows an earlier an [Read more]

IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
Opt-in for
REGN alerts

from News Quantified
Opt-in for
REGN alerts

from News Quantified